The GWbiohealth promise

Making Great Wellness a Reality Through Better Bioavailability

GWbiohealth combines precision engineering, advanced delivery science and rigorous research to help science-backed wellness ingredients reach their full potential.

Scientists working in a modern biotechnology laboratory
RESEARCH · ENGINEERING · BIOAVAILABILITY
Precision wellness
platform
Advanced science.
Purposeful delivery.
Cellular renewal, precisely delivered.
01
Nasal
Needle-free, metered delivery
02
Topical
Skin, scalp and wound applications
03
Oral
Drops, films and troches
04
Partner
Custom label and licensing
PRECISION CELLULAR WELLNESS

Engineering the
Future of Precision
Wellness

At GWbiowealth, we develop advanced delivery technologies that help maximize the potential of science-backed wellness ingredients. By combining precision engineering, innovative manufacturing and rigorous research, we are creating a new generation of products designed for modern health.

GWbiowealth’s patented R3a Nano-Fusion is an active-agnostic solubilization and delivery platform—not a product or formula. It converts difficult-to-deliver actives into a stable, approximately 32 nm aqueous colloidal carrier system. The active is the variable; the carrier architecture is the constant.

THE GOVERNING PRINCIPLE

Maximum active-
molecule surface area

+

Rapid penetration

= Increased bioavailability
PARTNER TECHNOLOGY OVERVIEW

One platform. Any active. Better
bioavailability.

R3a Nano-Fusion is an active-agnostic solubilization and delivery platform built to move difficult molecules where they need to go.

Cellular renewal, precisely delivered.

Three pillars. One invention.

No single component is the technology. R3a Nano-Fusion is the engineered combination of carrier, process and payload.

01
THE CARRIER

R3a matrix

A nonionic biopolymer carrier built on a USP/NF monograph excipient with an established pharmaceutical record.

02
THE PROCESS

Thermal Fusion

A controlled fusion process designed to drive the active into molecular dispersion—the technical core of the platform.

03
THE PAYLOAD

Active ingredient

A flexible architecture for peptides, retinoids, boswellic acids, cannabinoids and other difficult-to-deliver actives.

See how the platform works →

Two delivery systems

Engineered for the
molecule.

The architecture stays consistent while the process adapts to the active— heat-compatible molecules use Thermal Fusion; fragile peptides and NAD+ use Cold Fusion.

Hydrophobic actives

Thermal Fusion

Molecular dispersion for topical and oral delivery, designed to eliminate suspended crystals and create a stable bonded colloid.

Watch the Thermal Fusion video →

Hydrophilic actives

Cold Fusion

Protective, thermosensitive delivery for NAD+ and peptides—liquid at dosing and designed to form a mucosal-adherent gel.

Watch the MitOJet NAD+ video →
INDEPENDENT THIRD-PARTY TESTING

Evidence, not ornament.

The new website gives the scientific proof room to breathe—pairing concise claims with clear test context and a direct path to the supporting data.

Review the evidence →
32.3 nm Carrier D50 confirmed by
Microtrac DLS
251 µg/cm² CBD permeated in the 16-hour
model
60 / 40 Permeated delivery / skin-
associated reservoir
100% Sub-dermal absorption reported in
the tested model
PARTNER WITH US

A licensable
platform. Built for partners.

From intermediate supply to formulation, custom labeling and process transfer, GWbiohealth helps partners build differentiated products on a repeatable delivery platform.